BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
US Army

Generated: March 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020289

« Back to Dashboard

NDA 020289 describes GYNE-LOTRIMIN COMBINATION PACK, which is a drug marketed by Bayer Healthcare Llc and is included in one NDA. Additional details are available on the GYNE-LOTRIMIN COMBINATION PACK profile page.

The generic ingredient in GYNE-LOTRIMIN COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 020289
Applicant:Bayer Healthcare Llc
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020289

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CREAM, TABLET;TOPICAL, VAGINALStrength1%,100MG
Approval Date:Apr 26, 1993TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.